BACKGROUND
With increasing detection of asymptomatic or limited metastatic esophagogastric adenocarcinoma (mEAC), deferring systemic therapy may spare patients toxicity and hospital visits, but its impact on overall survival (OS) and health-related quality of life (HRQoL) is unclear.
METHODS
Patients diagnosed with m...
D. Kamp, A. May, Rob Kessels et al.· European Journal of Cancer· 0 citations
Clinicians' responses to perceived decision making burden in patients were variable, and discussions about how to navigate tensions between autonomy and avoiding harm could foster greater unity among clinicians on addressing patients' burden in SDM.
F. Huijgens, Inge Henselmans, M. Huisinga et al.· Journal of general internal...· 0 citations
This systematic review identified and compared published studies that developed TTE prediction methodologies using repeated covariate measurements to predict clinical outcomes and cluster them into families of methodologies.
I. Cara, Frederik H Erdmann, C. Attanasio et al.· Journal of Biomedical Inform...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.